Maximaa Systems financials and balance sheet

BSE: 526538Pharmaceuticals & Biotechnology

Trading suspended since 14 Dec 2021

Last traded ₹0.84 on 13 Dec 2021

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Maximaa Systems annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹28 Cr, year to Mar 2014A loss in 4 of the 9 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue1.0
  2. Materials and goods−5.5
  3. Employee costs0.0
  4. Other expenses−0.3
  5. Operating profit−4.9
  6. Depreciation0.0
  7. Other income+0.1
  8. One-off items−2.9
  9. Finance costs0.0
  10. Profit before tax−7.6
  11. Tax0.0
  12. Net profit−7.6

What the company owns

  • Receivables₹4 Cr
  • Plant, investments and other assets₹3 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹13 Cr
  • Owed to suppliers₹4 Cr

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the year to Mar 2016.Maximaa Systems quarterly results

₹ croreMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Filed 8 AugMar 2021Filed 9 Jul
Revenue from operations20.724.328.325.3–12.312.211.23.71.0
19.122.125.722.8–11.211.610.021.55.9
Materials and goods bought13.716.120.717.0–6.77.35.417.75.5
Employee costs2.32.62.33.1–2.52.2–1.30.0
Other expenses3.13.42.72.6–2.02.1–2.50.3
Operating profit before depreciation1.62.22.72.5–1.10.51.2−17.8−4.9
Operating margin7.6%9.2%9.4%10.0%–8.6%4.3%10.5%−477.7%−490.8%
Materials, % of revenue66.1%66.2%73.1%67.1%–54.2%60.2%–475.2%555.6%
Employee costs, % of revenue11.2%10.6%8.0%12.4%–20.5%18.3%–35.1%5.0%
Other expenses, % of revenue15.0%13.9%9.5%10.5%–16.7%17.2%–67.4%30.2%
Depreciation and amortisation1.61.71.70.7–0.70.71.61.40.0
Operating profit after depreciation−0.10.61.01.9–0.4−0.2−0.5−19.2−4.9
Other income0.00.00.30.3–0.00.20.50.00.1
Finance costs0.81.21.22.1–0.10.00.00.10.0
Profit before one-off items and tax−0.9−0.50.10.0–0.30.00.0−19.3−4.8
One-off items––––––––0.0−2.9
Profit before tax−0.9−0.50.10.0–0.30.00.0−19.3−7.6
Tax0.0–0.10.0––––0.00.0
Net profit−0.9−0.50.00.0–0.30.00.0−19.3−7.6
Net margin−4.3%−2.3%0.2%0.1%–2.1%0.0%0.1%−517.2%−770.9%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2019 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2021, after the latest full year: the balance sheet at its end.

₹ croreMar 2020Filed 8 AugMar 2021Filed 9 JulSep 2021Half yearFiled 22 Nov
−3.6−11.2−11.2
Share capital11.611.611.6
Reserves−15.2−22.8−22.8
20.812.512.5
18.212.612.6
8.75.55.5
Total assets23.36.96.9
12.92.32.3
10.44.54.5
Net debt20.712.512.5
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2017, Mar 2018 and Mar 2019, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2021, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Filed 9 JulSep 2021Half yearFiled 22 Nov
−7.30.0
−7.30.0
0.30.0
Receivables0.70.0
Inventories5.10.0
Payables−0.20.0
Other working capital−5.30.0
Capital spending0.00.0
Free cash flow−7.30.0
Cash from investing10.50.0
Cash from financing−3.20.0
Dividends paid0.00.0
Shares bought back0.00.0
Shares issued0.00.0
Net change in cash0.00.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Filed 8 AugMar 2021Filed 9 Jul
Earnings per share−₹0.11₹0.01––₹0.05₹0.00₹0.06−₹0.33−₹1.30
Diluted earnings per share–––––₹0.00₹0.06−₹0.33−₹1.30
Book value per share––––––––−₹1.93
Shareholder yield––––––––0.0%
Market cap at the year end (₹ crore)11.59.9––––24.7–9.3

Ratios

Standalone, years to March.

RatioMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Filed 8 AugMar 2021Filed 9 Jul
Revenue growth8.8%17.7%16.5%−10.7%––−0.9%−8.4%−66.6%−73.4%
Operating profit growth−33.4%43.5%18.1%−4.3%––−49.8%122.7%––
Net profit growth–––−67.3%––−99.2%350.0%––
Earnings per share growth––––––−98.1%5,900.0%––
––––––––539.9%103.4%
–––––––––−436.6 pts
From the net margin–––––––––264.8 pts
From asset turnover–––––––––−474.3 pts
From borrowing–––––––––−227.1 pts
Return on capital employed––––––––−111.8%−373.2%
Interest cover–0.50.80.9–4.5––––
Receivable days––––––––4921,585
Inventory days––––––––1060
Payable days––––––––96292
Cash conversion cycle, days––––––––5021,292
Working capital days––––––––453−261
Asset turnover––––––––0.160.07
Assets per rupee of net worth––––––––−6.52−2.04
Sales per rupee of plant––––––––0.35–
Plant being built, % of plant in use––––––––0.0%–
Interest cover is left blank for the years to Mar 2012, Mar 2018, Mar 2019 and Mar 2020: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the years to Mar 2020 and Mar 2021: net worth is below zero, so there is no shareholders' money to set the borrowings against. No balance sheet is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2017, Mar 2018 and Mar 2019, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Return on assets, latest year
−50.7%
Measure10 years5 years3 years
Revenue growth, yearly rate−25.6%–−56.7%
Return on equity, average––321.7%
Return on capital employed, average––−242.5%
Operating margin, average−101.0%−189.0%−319.3%
Net margin, average−143.6%−257.2%−429.3%
Asset turnover, average––0.11
Cash conversion cycle, days, average––897

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2021.

₹ croreLatest year
Cash from operations−7.3
Cash from investing10.5
Cash from financing−3.2
Capital spending0.0
Dividends paid0.0
Shares bought back0.0
Shares issued for cash0.0
Borrowings raised0.0
Borrowings repaid3.2

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Effective tax ratePublished threshold 17.16 per cent51.96−6.67––––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
29 Jan 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Term LoanLong-term scaleCARE D; ISSUER NOT COOPERATING*Review, Re-affirm1.33
29 Jan 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Cash CreditLong-term scaleCARE D; ISSUER NOT COOPERATING*Review, Re-affirm5
29 Jan 2026CARE Ratings Limited (opens in a new tab)Non-fund-based - ST-BG/LCShort-term scaleCARE D; ISSUER NOT COOPERATING*Review, Re-affirm2
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.